New paper from lab: many congratulations to Rebecca, Alia and Lucy who led this work. And thanks to all collaborators and funders. @paediatrics.ox.ac.uk @imm.ox.ac.uk @oxfordcancer.bsky.social ashpublications.org/blood/articl...
Wonderful work @abattacks.bsky.social ! Great to see this out. Many congratulations!
Concluding our interviews for #InternationalDayofWomenAndGirlsInScience2026, hear from DPhil in Cancer Science alumna, Rebecca Ling, now a Clinical Postdoctoral Fellow in @paediatrics.ox.ac.uk ⬇️ @medsci.ox.ac.uk
www.cancer.ox.ac.uk/news/interna...
Video
Key Points. LIN28B, a fetal specific oncogene, is necessary for fetal B lymphopoiesis and KMT2A::AFF1 initiation of infant B ALLLIN28B stabilizes key fetal
Great 3 days at the @cancerresearchuk.org Data conference in Edinburgh: lots of food for thought. Was good to see #CYP cancer data/AI being discussed.
Oxford's cancer researchers showcased cutting-edge data science and collaboration at @cancerresearchuk.org 's 2026 Data-Driven Cancer Research Conference this week, reinforcing Oxford’s pivotal role in progressing CRUK’s research data strategy. 👏
www.cancer.ox.ac.uk/news/oxford-...
Andi Roy
Andi Roy
Oxford Cancer
bloodpodcast.transistor.fm/episodes/147...
Another step on the journey towards building human bone marrow in vitro:
doi.org/10.1016/j.st...
When we published our first version a few years ago (doi.org/10.1158/2159...) the glaring gap was the lack of mature osteolineage (bone forming) cells, adipocytes, and lymphoid cells.
Oxford University cancer researchers showcased cutting-edge data science and collaboration at Cancer Research UK’s 2026 Data-Driven Cancer Research Conference, reinforcing Oxford’s pivotal role in pro...
In this week's episode, Blood editor Dr. Laurie Sehn interviews authors Drs. Anastasios Karadimitris and Maria Carolina Florian on their papers published in Volume 147 Issue 2 of Blood. Dr. Karadim...
#ScientistSpotlight 🧪
This week we’re featuring Emily Neil, a Postdoctoral Research Associate at the #MRCWIMM
Emily is working on a particularly aggressive and treatment resistant subtype of childhood B cell acute lymphoblastic leukaemia (B ALL), defined by the TCF3::HLF gene fusion.
Abs Khan
#WorldCancerDay | When time matters, waiting is not an option.
Researchers at #MRCWIMM have developed a readily available immunotherapy approach that showed promise against difficult to treat childhood #leukaemia in early stage #research. 🧪
#ChildhoodCancer #CancerResearch
This Sunday is #InternationalWomensDay 🧪
Each year we take our Women of WIMM group photo, celebrating women across our entire community, from research and technical teams to professional services.
Here is to the women of #MRCWIMM.
@rdm.ox.ac.uk @medsci.ox.ac.uk @ox.ac.uk
#WorldCancerDay Discovery and early detection matter 🧪
Research at #MRCWIMM shows that platelets carry #DNA, offering new insights into cancer biology and early detection through fundamental science.
#CancerResearch #EarlyDetection
@bethpsaila.bsky.social @rdm.ox.ac.uk @ox.ac.uk @medsci.ox.ac.uk 🧬
Scientists at the University of Oxford, together with colleagues at Imperial College London and the University of Glasgow, have developed a new type of immunotherapy that could improve outcomes for in...
Study led by Psaila Group uncovers previously unknown function of platelets as DNA ‘vacuum cleaners’ in the blood, with profound implications for cancer diagnosis and prenatal screening.
